182 related articles for article (PubMed ID: 9300780)
1. Adenoviral vector-mediated overexpression of serum amyloid A in apoA-I-deficient mice.
Webb NR; de Beer MC; van der Westhuyzen DR; Kindy MS; Banka CL; Tsukamoto K; Rader DL; de Beer FC
J Lipid Res; 1997 Aug; 38(8):1583-90. PubMed ID: 9300780
[TBL] [Abstract][Full Text] [Related]
2. Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice.
Hosoai H; Webb NR; Glick JM; Tietge UJ; Purdom MS; de Beer FC; Rader DJ
J Lipid Res; 1999 Apr; 40(4):648-53. PubMed ID: 10191288
[TBL] [Abstract][Full Text] [Related]
3. Expression of mouse acute-phase (SAA1.1) and constitutive (SAA4) serum amyloid A isotypes: influence on lipoprotein profiles.
Kindy MS; de Beer MC; Yu J; de Beer FC
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1543-50. PubMed ID: 10845870
[TBL] [Abstract][Full Text] [Related]
4. SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I-/- mice.
Cabana VG; Reardon CA; Wei B; Lukens JR; Getz GS
J Lipid Res; 1999 Jun; 40(6):1090-103. PubMed ID: 10357841
[TBL] [Abstract][Full Text] [Related]
5. Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro.
Cabana VG; Feng N; Reardon CA; Lukens J; Webb NR; de Beer FC; Getz GS
J Lipid Res; 2004 Feb; 45(2):317-25. PubMed ID: 14595002
[TBL] [Abstract][Full Text] [Related]
6. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice.
Tietge UJ; Maugeais C; Lund-Katz S; Grass D; deBeer FC; Rader DJ
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1213-8. PubMed ID: 12117740
[TBL] [Abstract][Full Text] [Related]
7. SR-BI selective lipid uptake: subsequent metabolism of acute phase HDL.
de Beer MC; Webb NR; Whitaker NL; Wroblewski JM; Jahangiri A; van der Westhuyzen DR; de Beer FC
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1298-303. PubMed ID: 19304574
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid A is not incorporated into HDL during HDL biogenesis.
Ji A; Wang X; Noffsinger VP; Jennings D; de Beer MC; de Beer FC; Tannock LR; Webb NR
J Lipid Res; 2020 Mar; 61(3):328-337. PubMed ID: 31915139
[TBL] [Abstract][Full Text] [Related]
9. Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice.
Kim MH; de Beer MC; Wroblewski JM; Charnigo RJ; Ji A; Webb NR; de Beer FC; van der Westhuyzen DR
J Lipid Res; 2016 Jun; 57(6):969-79. PubMed ID: 27018443
[TBL] [Abstract][Full Text] [Related]
10. Amyloid formation in the rat: adenoviral expression of mouse serum amyloid A proteins.
Yu J; Guo JT; Zhu H; Kindy MS
Amyloid; 2000 Mar; 7(1):32-40. PubMed ID: 10842703
[TBL] [Abstract][Full Text] [Related]
11. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages.
Artl A; Marsche G; Lestavel S; Sattler W; Malle E
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):763-72. PubMed ID: 10712402
[TBL] [Abstract][Full Text] [Related]
12. Impact of serum amyloid A on high density lipoprotein composition and levels.
de Beer MC; Webb NR; Wroblewski JM; Noffsinger VP; Rateri DL; Ji A; van der Westhuyzen DR; de Beer FC
J Lipid Res; 2010 Nov; 51(11):3117-25. PubMed ID: 20667817
[TBL] [Abstract][Full Text] [Related]
13. [Effects of Chinese herbal medicine Guanxinkang on lipid metabolism and serum C-reactive protein, amyloid A protein and fibrinogen in apolipoprotein E-knockout mice with atherosclerosis].
Mao MJ; Hu JP; Chen FR; Zhang YY; Liu P
Zhong Xi Yi Jie He Xue Bao; 2011 Mar; 9(3):306-12. PubMed ID: 21419084
[TBL] [Abstract][Full Text] [Related]
14. Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice.
Spangenberg J; Curtiss LK
Biochim Biophys Acta; 1997 Nov; 1349(2):109-21. PubMed ID: 9421184
[TBL] [Abstract][Full Text] [Related]
15. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV.
Duverger N; Tremp G; Caillaud JM; Emmanuel F; Castro G; Fruchart JC; Steinmetz A; Denèfle P
Science; 1996 Aug; 273(5277):966-8. PubMed ID: 8688083
[TBL] [Abstract][Full Text] [Related]
16. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
[TBL] [Abstract][Full Text] [Related]
17. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse.
Lindhorst E; Young D; Bagshaw W; Hyland M; Kisilevsky R
Biochim Biophys Acta; 1997 Apr; 1339(1):143-54. PubMed ID: 9165109
[TBL] [Abstract][Full Text] [Related]
18. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
[TBL] [Abstract][Full Text] [Related]
19. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):785-90. PubMed ID: 15692094
[TBL] [Abstract][Full Text] [Related]
20. Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus.
Tsukamoto K; Hiester KG; Smith P; Usher DC; Glick JM; Rader DJ
J Lipid Res; 1997 Sep; 38(9):1869-76. PubMed ID: 9323596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
